ARC
KIN

Absolute Return Capital’s Kindred Biosciences, Inc. KIN Stock Holding History

Absolute Return Capital’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,904
Closed -$104K – 663
2014
Q4 		$104K Sell
13,904
-42,090
-75% -$357K ﹤0.01% 610
2014
Q3 		$518K Buy
55,994
+13,720
+32% +$185K 0.01% 573
2014
Q2 		$788K Buy
+42,274
New +$718K 0.01% 731

Other funds holding KIN

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Absolute Return Capital's KIN Position: Q1 2015 in Review

Absolute Return Capital sold out of Kindred Biosciences, Inc. (KIN) in Q1 2015, closing a stake of 13,904 shares — an estimated $104K sold.

Absolute Return Capital first reported a position in KIN in Q2 2014 and held it in 3 quarters. The position peaked at $788K in Q2 2014. 60 funds tracked by Wall St. Rank hold KIN as of Q1 2015.

  • Absolute Return Capital reported no remaining Kindred Biosciences, Inc. position as of Q1 2015 after selling out during the quarter.
  • Absolute Return Capital sold 13,904 Kindred Biosciences, Inc. shares in Q1 2015, an estimated $104K.
  • Absolute Return Capital first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 3 quarters.
  • Absolute Return Capital's Kindred Biosciences, Inc. position peaked at $788K in Q2 2014.
  • 60 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2015.

Based on Absolute Return Capital's 13F filing for Q1 2015, filed 15 May 2015.